 |
PDBsum entry 4b6c
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Aminopyrazinamides: novel and specific gyrb inhibitors that kill replicating and nonreplicating mycobacterium tuberculosis.
|
 |
|
Authors
|
 |
P.S.Shirude,
P.Madhavapeddi,
J.A.Tucker,
K.Murugan,
V.Patil,
H.Basavarajappa,
A.V.Raichurkar,
V.Humnabadkar,
S.Hussein,
S.Sharma,
V.K.Ramya,
C.B.Narayan,
T.S.Balganesh,
V.K.Sambandamurthy.
|
 |
|
Ref.
|
 |
Acs Chem Biol, 2013,
8,
519-523.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
Aminopyrazinamides originated from a high throughput screen targeting the
Mycobacterium smegmatis (Msm) GyrB ATPase. This series displays chemical
tractability, robust structure-activity relationship, and potent antitubercular
activity. The crystal structure of Msm GyrB in complex with one of the
aminopyrazinamides revealed promising attributes of specificity against other
broad spectrum pathogens and selectivity against eukaryotic kinases due to novel
interactions at hydrophobic pocket, unlike other known GyrB inhibitors. The
aminopyrazinamides display excellent mycobacterial kill under in vitro,
intracellular, and hypoxic conditions.
|
 |
|
|
|
|
 |